These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26966889)

  • 1. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rodent models for the study of therapy against flavivirus infections.
    Charlier N; Leyssen P; De Clercq E; Neyts J
    Antiviral Res; 2004 Aug; 63(2):67-77. PubMed ID: 15321702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to flavivirus drug discovery.
    Botting C; Kuhn RJ
    Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present perspectives on flaviviral chemotherapy.
    Ghosh D; Basu A
    Drug Discov Today; 2008 Jul; 13(13-14):619-24. PubMed ID: 18598919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on flaviviruses: current and future drug targets.
    Geiss BJ; Stahla H; Hannah AM; Gari AM; Keenan SM
    Future Med Chem; 2009 May; 1(2):327-44. PubMed ID: 20165556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View.
    Felicetti T; Manfroni G; Cecchetti V; Cannalire R
    ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New approaches to the treatment of the flavivirus infections].
    Morozova OV; Isaeva EI; Viazov SO
    Vopr Virusol; 2015; 60(6):5-9. PubMed ID: 27024909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Phytochemical Compounds as Antiviral Agents Against Arboviruses from the Genera Flavivirus and Alphavirus.
    Sardari S; Rafieian-Kopaei M; Malekmohammad K; Sewell RDE
    Curr Drug Discov Technol; 2020; 17(4):484-497. PubMed ID: 31969106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Targets for the Treatment of Flavivirus Infections.
    Zakaria MK; Carletti T; Marcello A
    Front Cell Infect Microbiol; 2018; 8():398. PubMed ID: 30483483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavivirus capsid protein: Structure, function and perspectives towards drug design.
    Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC
    Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
    Eyer L; Nencka R; de Clercq E; Seley-Radtke K; Růžek D
    Antivir Chem Chemother; 2018; 26():2040206618761299. PubMed ID: 29534608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding new medicines for flaviviral targets.
    Keller TH; Chen YL; Knox JE; Lim SP; Ma NL; Patel SJ; Sampath A; Wang QY; Yin Z; Vasudevan SG
    Novartis Found Symp; 2006; 277():102-14; discussion 114-9, 251-3. PubMed ID: 17319157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.
    Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL
    ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel antivirals against flaviviruses.
    Patkar CG; Kuhn RJ
    Novartis Found Symp; 2006; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of viral and cellular factors on flavivirus entry.
    Cordero-Rivera CD; De Jesús-González LA; Osuna-Ramos JF; Palacios-Rápalo SN; Farfan-Morales CN; Reyes-Ruiz JM; Del Ángel RM
    Curr Opin Virol; 2021 Aug; 49():164-175. PubMed ID: 34171540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.